Another significantly upregulated protein in AD-MSCs and validated target for miR-155-5p, is the proinflammatory cytokine Chemokine (CC-motif) ligand 2 (CCL2) a.k.a Monocyte chemotactic protein-1 (MCP1). Here, CCL2 is linked to Alzheimer disease.